Australia markets open in 6 hours 28 minutes

Leap Therapeutics, Inc. (LPTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2500+0.0800 (+2.52%)
At close: 04:00PM EDT
3.2000 -0.05 (-1.54%)
After hours: 06:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
1,500
1,500
Operating expenses
Research development
73,234
73,234
44,965
32,160
20,423
Selling general and administrative
13,807
13,807
11,798
10,766
9,616
Total operating expenses
85,940
85,940
54,712
41,700
29,808
Operating income or loss
-85,940
-85,940
-54,712
-40,200
-28,308
Interest expense
0
0
54
41
39
Total other income/expenses net
499
499
-608
-379
738
Income before tax
-81,414
-81,414
-54,449
-40,611
-27,516
Income tax expense
0
0
147
-24
-2
Income from continuing operations
-81,414
-81,414
-54,596
-40,587
-27,514
Net income
-81,414
-81,414
-54,596
-40,587
-27,514
Net income available to common shareholders
-81,414
-81,414
-54,596
-40,587
-37,588
Basic EPS
-4.83
-
-4.82
-4.70
-6.30
Diluted EPS
-4.83
-
-4.82
-4.70
-6.30
Basic average shares
16,511
-
11,324
8,583
5,933
Diluted average shares
16,511
-
11,324
8,583
5,933